Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|October 6, 2018
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert ConsensusMonica Todoerti, Ennio Giulio Favalli, Florenzo Iannone, et al.
Journal of Neurology|December 25, 2013
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy featuresMarina de Tommaso, Maria Nolano, Florenzo Iannone, et al.
Clinical Rheumatology|April 13, 2017
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's diseaseAntonio Vitale, Giacomo Emmi, Giuseppe Lopalco, et al.
Clinical and Experimental Rheumatology|June 20, 2015
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar yearsFlorenzo Iannone, Fausto Salaffi, Antonio Marchesoni, et al.
The Israel Medical Association Journal : IMAJ|August 16, 2018
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral CentersStefano Gentileschi, Antonio Vitale, Donato Rigante, et al.
Autoimmunity Reviews|October 20, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian expertsEnnio Giulio Favalli, Andrea Becciolini, Roberto Caporali, et al.
Clinical Rheumatology|July 10, 2015
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective studyGiacomo Emmi, Rosaria Talarico, Giuseppe Lopalco, et al.
Annals of the Rheumatic Diseases|July 14, 2006
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effectsFlorenzo Iannone, Francesco Trotta, Carlomaurizio Montecucco, et al.
Clinical and Experimental Rheumatology|April 27, 2019
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective surveyGiuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
Pageof 12